Relation between depressive symptoms and treadmill exercise capacity in the Heart and Soul Study.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 2776667)

Published in Am J Cardiol on July 01, 2004

Authors

Bernice Ruo1, John S Rumsfeld, Sharon Pipkin, Mary A Whooley

Author Affiliations

1: Section of General Internal Medicine, VA Medical Center, and Department of Medicine, University of California, San Francisco, USA. berniceruo@post.harvard.edu

Articles citing this

Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA (2008) 6.50

Depression and cardiovascular disease: healing the broken-hearted. JAMA (2006) 2.44

Telomere length trajectory and its determinants in persons with coronary artery disease: longitudinal findings from the heart and soul study. PLoS One (2010) 2.10

C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study. Eur J Heart Fail (2007) 1.10

Self-efficacy and health status in patients with coronary heart disease: findings from the heart and soul study. Psychosom Med (2007) 0.98

Association between depression and peripheral artery disease: insights from the heart and soul study. J Am Heart Assoc (2012) 0.91

Depression predicts failure to complete phase-II cardiac rehabilitation. J Behav Med (2008) 0.88

Self-efficacy as a marker of cardiac function and predictor of heart failure hospitalization and mortality in patients with stable coronary heart disease: findings from the Heart and Soul Study. Health Psychol (2009) 0.88

Rank, job stress, psychological distress and physical activity among military personnel. BMC Public Health (2013) 0.80

Hostility, health behaviors, and risk of recurrent events in patients with stable coronary heart disease: findings from the Heart and Soul Study. J Am Heart Assoc (2013) 0.79

Depressive symptomatology, exercise adherence, and fitness are associated with reduced cognitive performance in heart failure. J Aging Health (2013) 0.78

An examination of psychosocial correlates of exercise tolerance in cardiac rehabilitation participants. J Behav Med (2009) 0.76

Articles cited by this

The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med (2001) 76.04

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr (1990) 25.24

Exercise capacity and mortality among men referred for exercise testing. N Engl J Med (2002) 14.30

Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 8.28

Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol (1995) 7.64

Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01

Self-rated health and mortality in the NHANES-I Epidemiologic Follow-up Study. Am J Public Health (1990) 6.60

ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation (2002) 4.56

Importance of functional measures in predicting mortality among older hospitalized patients. JAMA (1998) 4.33

Health status predicts long-term outcome in outpatients with coronary disease. Circulation (2002) 4.10

Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Department of Veterans Affairs Cooperative Study Group on Processes, Structures, and Outcomes of Care in Cardiac Surgery. JAMA (1999) 2.70

Selective serotonin reuptake inhibitors and myocardial infarction. Circulation (2001) 2.14

Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation (2003) 1.59

Clinical implications of a reduction in psychological distress on cardiac prognosis in patients participating in a psychosocial intervention program. Psychosom Med (2001) 1.16

Risk factors for intermediate-term survival after coronary artery bypass grafting. Ann Thorac Surg (2001) 1.15

Determinants of physical functioning in coronary patients: response to cardiac rehabilitation. Arch Intern Med (1999) 1.03

Changes in perceived health status of depressed elderly patients treated until remission. Am J Psychiatry (1996) 0.99

Performance-based and self-reported physical functioning in low-functioning older persons: congruence of change and the impact of depressive symptoms. J Gerontol B Psychol Sci Soc Sci (1999) 0.92

Health care utilization and costs of adult cardiovascular conditions United States, 1980. Natl Med Care Util Expend Surv C (1989) 0.80

Articles by these authors

Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA (2013) 12.37

Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med (2013) 8.08

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA (2009) 7.78

ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol (2006) 7.77

Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med (2006) 7.54

Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01

Medication adherence: its importance in cardiovascular outcomes. Circulation (2009) 5.30

Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA (2002) 5.07

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med (2010) 4.89

Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med (2006) 4.44

Appropriateness of percutaneous coronary intervention. JAMA (2011) 4.33

Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA (2008) 4.06

Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA (2007) 3.79

Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med (2008) 3.68

Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA (2008) 3.55

Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul study. Arch Intern Med (2012) 3.50

Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation (2006) 3.45

Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J (2008) 3.40

Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J (2005) 3.26

Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc (2002) 3.03

Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA (2010) 2.98

Outcomes following transcatheter aortic valve replacement in the United States. JAMA (2013) 2.88

Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol (2010) 2.86

B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation (2003) 2.82

Additive effects of cognitive function and depressive symptoms on mortality in elderly community-living adults. J Gerontol A Biol Sci Med Sci (2003) 2.82

Comparison of clinical interpretation with visual assessment and quantitative coronary angiography in patients undergoing percutaneous coronary intervention in contemporary practice: the Assessing Angiography (A2) project. Circulation (2013) 2.81

Depression and heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Arch Gen Psychiatry (2005) 2.73

N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA (2007) 2.67

Cardiac performance measure compliance in outpatients: the American College of Cardiology and National Cardiovascular Data Registry's PINNACLE (Practice Innovation And Clinical Excellence) program. J Am Coll Cardiol (2010) 2.62

Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2006) 2.61

Factors associated with racial differences in myocardial infarction outcomes. Ann Intern Med (2009) 2.54

The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012. J Am Coll Cardiol (2012) 2.50

Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol (2010) 2.49

Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv (2008) 2.48

All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients. J Am Coll Cardiol (2009) 2.40

Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study. Circulation (2004) 2.39

Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study. JACC Cardiovasc Imaging (2009) 2.38

Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am J Psychiatry (2007) 2.37

Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med (2007) 2.34

Finding the courage to reconsider medical therapy for stable angina. N Engl J Med (2008) 2.30

Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. Am J Epidemiol (2014) 2.30

Central nervous system active medications and risk for fractures in older women. Arch Intern Med (2003) 2.30

Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients. JAMA (2011) 2.29

Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med (2005) 2.28

Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation (2006) 2.27

Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2007) 2.23

Clinical features and outcomes of carotid artery stenting by clinical expert consensus criteria: a report from the CARE registry. Catheter Cardiovasc Interv (2010) 2.21

The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol (2007) 2.19

Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study). Am J Cardiol (2005) 2.18

ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). Circulation (2006) 2.12

Telomere length trajectory and its determinants in persons with coronary artery disease: longitudinal findings from the heart and soul study. PLoS One (2010) 2.10

The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes (2008) 2.03

Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative. J Am Coll Cardiol (2007) 2.03

Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease:The Heart and Soul Study. Arch Gen Psychiatry (2010) 1.99

Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol (2006) 1.98

The Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER)--evaluating the impact of myocardial infarction on patient outcomes. Am Heart J (2006) 1.98

Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the Heart and Soul Study. Circulation (2010) 1.97

ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance. Endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine. J Am Soc Echocardiogr (2007) 1.96

Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease. J Am Coll Cardiol (2010) 1.96

Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes. J Am Soc Nephrol (2013) 1.95

Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am J Psychiatry (2011) 1.92

Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul Study. Arterioscler Thromb Vasc Biol (2008) 1.92

ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society of America. Circulation (2005) 1.90

Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice. Arch Intern Med (2012) 1.89

A call to ACTION (acute coronary treatment and intervention outcomes network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction. Circ Cardiovasc Qual Outcomes (2009) 1.86

Blood pressure reactivity to psychological stress and coronary calcification in the Coronary Artery Risk Development in Young Adults Study. Hypertension (2006) 1.86

Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study. Am J Kidney Dis (2011) 1.83

ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol (2005) 1.76

Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study). Am J Cardiol (2008) 1.75

ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol (2006) 1.74

Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association. Circulation (2013) 1.73

Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study. J Am Soc Nephrol (2003) 1.72

Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA (2010) 1.71

Association of patient case-mix adjustment, hospital process performance rankings, and eligibility for financial incentives. JAMA (2008) 1.69

The NCDR ACTION Registry-GWTG: transforming contemporary acute myocardial infarction clinical care. Heart (2010) 1.67

Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. JAMA (2009) 1.63

Symptom burden, depression, and spiritual well-being: a comparison of heart failure and advanced cancer patients. J Gen Intern Med (2009) 1.62

Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv (2009) 1.62

Association of exercise capacity on treadmill with future cardiac events in patients referred for exercise testing. Arch Intern Med (2008) 1.62

High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study. JAMA Intern Med (2013) 1.62

Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm (2009) 1.60

ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol (2008) 1.60

Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation: insights from the HMO Research Network-Stent Registry (HMORN-stent). Circ Cardiovasc Interv (2010) 1.59

Influence of inpatient service specialty on care processes and outcomes for patients with non ST-segment elevation acute coronary syndromes. Circulation (2007) 1.59

The relationship between B-type natriuretic peptide and health status in patients with heart failure. J Card Fail (2005) 1.58

Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study. Am J Med (2004) 1.56

Mayo Clinic Risk Score for percutaneous coronary intervention predicts in-hospital mortality in patients undergoing coronary artery bypass graft surgery. Circulation (2008) 1.56

Prognostic value of low-level cardiac troponin-I elevations in patients without definite acute coronary syndromes. Am Heart J (2004) 1.55

Depression and cardiovascular disease: a call for recognition. Circulation (2005) 1.53

In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™. Am J Cardiol (2011) 1.53

Effects of sustained audit/feedback on self-reported health status of primary care patients. Am J Med (2004) 1.52

AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services endorsed by the American College of Chest Physicians, American College of Sports Medicine, American Physical Therapy Association, Canadian Association of Cardiac Rehabilitation, European Association for Cardiovascular Prevention and Rehabilitation, Inter-American Heart Foundation, National Association of Clinical Nurse Specialists, Preventive Cardiovascular Nurses Association, and the Society of Thoracic Surgeons. J Am Coll Cardiol (2007) 1.51

Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study. Nephrol Dial Transplant (2009) 1.51

Alcohol consumption and 5-year change in left atrial volume among patients with coronary heart disease: results from the Heart and Soul study. J Card Fail (2013) 1.50

Depression and leukocyte telomere length in patients with coronary heart disease: data from the Heart and Soul Study. Psychosom Med (2011) 1.49

Predictors of the onset of depressive symptoms in patients with heart failure. J Am Coll Cardiol (2004) 1.49

Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry. Ann Thorac Surg (2016) 1.48